NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Tirzepatide from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it for free.

Test my supply
+12 more ↓
81%
Finnrick rating
#70 of 262 Tirzepatide vendors
18 of 22 classifiable tests passed
customers 4.3★ (13)
methodology · Purity focus
Finnrick analysis · Tirzepatide

A February purity-miss cluster and one 99.4% purity, -46% fill result are the main drag on Shanxi Qianyecao Biotech QYC's Tirzepatide profile. Recent tests rebounded to 99.8-99.9% purity, but batch IDs are often missing.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanxi Qianyecao Biotech QYC

We investigated who actually operates Shanxi Qianyecao Biotech QYC — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

29 pages10 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.08
90%
13
2
Tirzepatideselected
$0.47
81%
22
3
Retatrutide
$1.20
73%
52
4
PT-141
$1.80
71%
3
5
Ipamorelin
$1.00
60%
5
6
Tesamorelin
$1.90
57%
12
7
Sermorelin
$2.00
47%
3
8
BPC-157
$1.29
45%
8
9
TB-500
$3.00
40%
4
10
Cagrilintide
$2.40
38%
5
11
NAD+
-
20%
4
12
CJC-1295
$2.00
-
0
13
Epithalon
$0.30
-
0
15
HGH
-
-
0
16
KLOW
-
-
0
17
KPV
-
-
0
18
Semaglutide
$2.00
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Jun 2025: 66%5 Aug 2025: 71%3 Oct 2025: 81%14 Oct 2025: 76%5 Nov 2025: 78%18 Dec 2025: 79%1 Jan 2026: 81%9 Jan 2026: 82%15 Jan 2026: 84%15 Jan 2026: 85%15 Jan 2026: 85%15 Jan 2026: 86%2 Feb 2026: 82%2 Feb 2026: 78%18 Feb 2026: 75%1 Mar 2026: 76%29 Mar 2026: 77%28 Apr 2026: 78%6 May 2026: 79%6 May 2026: 80%6 May 2026: 80%21 Jul 2026: 81%29 Sep 2026: current 81%66%79%81%Jun 25Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it for free.

Test my supply
Shanxi Qianyecao Biotech QYC Tirzepatide test history
COA-backed lab tests
1-10 of 22

About Shanxi Qianyecao Biotech QYC test results from Finnrick

Shanxi Qianyecao Biotech QYC is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 131 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanxi Qianyecao Biotech QYC peptides in this dataset are BPC-157 (8 tests), Cagrilintide (5 tests) and GHK-Cu (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 131 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-08-17
Finnrick data entry
The requester submitted the NAD+ sample with a declared potency of 50 mg. The correct potency is 500 mg. The recorded data has been corrected to reflect the accurate potency of 500 mg.
Free peptide testing

Ordered Tirzepatide from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it for free.

Test my supply